CVT-2

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NameCVT-2
Drug Alias NameN/A
ClassificationOther
Mechanisms of ActionComplement C5a stimulants
TargetsComplement C5a
Therapy Area/IndicationsAtherosclerosisMyocardial InfarctionRenal Insufficiency
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCv Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCv Therapeutics
Active IndicationsN/A
Inactive IndicationsAtherosclerosisMyocardial InfarctionRenal Insufficiency

Other Information

ATC CodeN/A
Related LinksN/A